KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intel (INTC) Asset Writedowns and Impairment: 2023-2025

Historic Asset Writedowns and Impairment for Intel (INTC) over the last 3 years, with Q3 2025 value amounting to -$4.0 million.

  • Intel's Asset Writedowns and Impairment fell 10011.79% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $831.0 million, marking a year-over-year decrease of 7699.34%. This contributed to the annual value of $3.6 billion for FY2024, which is 796888.89% up from last year.
  • Per Intel's latest filing, its Asset Writedowns and Impairment stood at -$4.0 million for Q3 2025, which was down 10011.79% from $416.0 million recorded in Q2 2025.
  • In the past 5 years, Intel's Asset Writedowns and Impairment registered a high of $3.4 billion during Q3 2024, and its lowest value of -$4.0 million during Q3 2025.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $19.0 million (2024), whereas its average is $579.4 million.
  • As far as peak fluctuations go, Intel's Asset Writedowns and Impairment surged by 9000.0% in 2024, and later plummeted by 10011.79% in 2025.
  • Quarter analysis of 3 years shows Intel's Asset Writedowns and Impairment stood at $10.0 million in 2023, then skyrocketed by 90.0% to $19.0 million in 2024, then plummeted by 121.05% to -$4.0 million in 2025.
  • Its Asset Writedowns and Impairment was -$4.0 million in Q3 2025, compared to $416.0 million in Q2 2025 and $3.0 million in Q1 2025.